| Lester G Carter | |
| Lester G Carter | |
| Seung Joong Kim | Department of Bioengineering and Therapeutic Sciences and Department of Pharmaceutical Chemistry and California Institute for Quantitative Biosciences (QB3), University of California San Francisco |
| Dina Schneidman-Duhovny | Department of Bioengineering and Therapeutic Sciences and Department of Pharmaceutical Chemistry and California Institute for Quantitative Biosciences (QB3), University of California San Francisco |
| Dina Schneidman-Duhovny | Department of Bioengineering and Therapeutic Sciences and Department of Pharmaceutical Chemistry and California Institute for Quantitative Biosciences (QB3), University of California San Francisco |
| Jan St??hr | Institute for Neurodegenerative Diseases, University of California San Francisco |
| Guillaume Poncet-Montange | Institute for Neurodegenerative Diseases, University of California San Francisco |
| Thomas M Weiss | |
| Thomas M Weiss | |
| Hiro Tsuruta | |
| Stanley B Prusiner | Institute for Neurodegenerative Diseases, University of California San Francisco |
| Andrej Sali (CM4AI) | Department of Bioengineering and Therapeutic Sciences and Department of Pharmaceutical Chemistry and California Institute for Quantitative Biosciences (QB3), University of California San Francisco |
| Andrej Sali (CM4AI) | Department of Bioengineering and Therapeutic Sciences and Department of Pharmaceutical Chemistry and California Institute for Quantitative Biosciences (QB3), University of California San Francisco |